Literature DB >> 21038159

Can training normalize atypical passive auditory ERPs in children with SRD or SLI?

Genevieve M McArthur1, Carmen M Atkinson, Danielle Ellis.   

Abstract

This study tested if training can normalize atypical passive auditory event-related potentials in the N1-P2 time window in children with specific reading disability (SRD) or specific language impairment (SLI). Children with SRD or SLI and untrained controls were tested for their behavioral responses and N1-P2 windows to tones, backward-masked tones, vowels, and consonant-vowels. Children with SRD or SLI with poor behavioral responses to one of these sounds trained to discriminate that sound for 30 minutes a day, 4 days a week, for 6 weeks. Post-training measures revealed that training normalized atypical behavioral responses but not atypical N1-P2 windows.

Entities:  

Mesh:

Year:  2010        PMID: 21038159     DOI: 10.1080/87565641.2010.508548

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  4 in total

1.  A validation of Emotiv EPOC Flex saline for EEG and ERP research.

Authors:  Nikolas S Williams; Genevieve M McArthur; Bianca de Wit; George Ibrahim; Nicholas A Badcock
Journal:  PeerJ       Date:  2020-08-11       Impact factor: 2.984

2.  Electrocortical Dynamics in Children with a Language-Learning Impairment Before and After Audiovisual Training.

Authors:  Sabine Heim; Naseem Choudhury; April A Benasich
Journal:  Brain Topogr       Date:  2015-12-15       Impact factor: 3.020

3.  Training-Induced Changes in Rapid Auditory Processing in Children With Specific Language Impairment: Electrophysiological Indicators.

Authors:  Anna Dacewicz; Aneta Szymaszek; Kamila Nowak; Elzbieta Szelag
Journal:  Front Hum Neurosci       Date:  2018-08-07       Impact factor: 3.169

4.  Left hemisphere enhancement of auditory activation in language impaired children.

Authors:  Sam van Bijnen; Salme Kärkkäinen; Päivi Helenius; Tiina Parviainen
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.